Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$13.80

-1.1 (-7.38%)

, HSY

Hershey

$96.48

-0.17 (-0.18%)

10:21
04/12/18
04/12
10:21
04/12/18
10:21

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mallinckrodt (MNK) initiated with a Hold at SunTrust. 2. Hershey (HSY) initiated with a Neutral at Piper Jaffray. 3. Autoliv (ALV) initiated with a Hold at Cross Research. 4. Leap Therapeutics (LPTX) initiated with a Buy at H.C. Wainwright. 5. Monolithic Power (MPWR) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

MNK

Mallinckrodt

$13.80

-1.1 (-7.38%)

HSY

Hershey

$96.48

-0.17 (-0.18%)

ALV

Autoliv

$149.69

0.14 (0.09%)

LPTX

Leap Therapeutics

$9.71

0.16 (1.68%)

MPWR

Monolithic Power

$116.98

1.14 (0.98%)

  • 12

    Apr

  • 13

    Apr

  • 24

    Apr

  • 26

    Apr

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 18

    May

  • 07

    Jun

  • 22

    Aug

MNK Mallinckrodt
$13.80

-1.1 (-7.38%)

04/11/18
RHCO
04/11/18
INITIATION
Target $15
RHCO
Hold
Mallinckrodt initiated with a Hold at SunTrust
SunTrust analyst John Boris initiated Mallinckrodt with a Hold and $15 price target.
03/16/18
WELS
03/16/18
NO CHANGE
Target $17.5
WELS
Market Perform
Mallinckrodt price target lowered to $17.50 from $22 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Mallinckrodt to $17.50 and keeps a Market Perform rating on the name. Management did not provide directional guidance for Acthar in 2019, which is concerning, Maris tells investors in a research note. Further, Mallinckrodt's 3%-6% sales growth guidance for 2018, which implies little to no organic growth, suggests Acthar is not the company's only product facing a challenging outlook, Maris adds.
02/02/18
LEHM
02/02/18
DOWNGRADE
Target $20
LEHM
Underweight
Mallinckrodt downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao downgraded Mallinckrodt to Underweight and cut his price target for the shares to $20 from $23. The acquisition of Sucampo (SCMP) does not address ongoing concern over Acthar and reduces the company's strategic options by raising leverage to 4.5 times, Tsao tells investors in a research note. Reimbursement pressure for Acthar could intensify, and, while not imminent, the franchise could face competition, the analyst adds.
01/09/18
BMOC
01/09/18
NO CHANGE
BMOC
Outperform
BMO Capital 'pleased' with Mallinckrodt steps to evolve portfolio
After Mallinckrodt (MNK) announced the divestiture of hemostasis products Recothrom and Preveleak to Baxter (BAX) for $185M, BMO Capital analyst Gary Nachman said he was "pleased" with these moves and the company's recent deal for Sucampo (SCMP) as steps toward evolving its portfolio and reducing Acthar concentration risk. While saying there is still more to do, Nachman believes Mallinckrodt's expanding pipeline warrants more attention and he keeps an Outperform rating on the stock.
HSY Hershey
$96.48

-0.17 (-0.18%)

04/10/18
04/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Monsanto (MON) downgraded to Market Perform from Outperform at BMO Capital with analyst Joel Jackson citing the rising likelihood of the acquisition by Bayer (BAYRY) after yesterday's reports of approval of the merger by the U.S. Department of Justice. 2. Hershey (HSY) downgraded to Sell from Neutral at UBS with analyst Steven Strycula saying Hershey's portfolio is over-exposed to slowing category consumption, intensifying competition, and rising cocoa prices. 3. Cullen/Frost (CFR) downgraded to Underperform from Market Perform at Raymond James. 4. vTv Therapeutics (VTVT) downgraded to Hold from Buy at Stifel, to Neutral from Buy at Seaport Global, Piper Jaffray, and Roth Capital, as well as to Market Perform from Outperform at Northland. 5. Radian Group (RDN) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Dwelle citing the latest reduction in borrower-paid premium rates at MGIC Investment (MTG) and saying he believes sentiment in the space will be negatively impacted. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/10/18
UBSW
04/10/18
DOWNGRADE
Target $90
UBSW
Sell
UBS downgrades Hershey to Sell on reduced chocolate buying frequency
UBS analyst Steven Strycula downgraded Hershey (HSY) to Sell from Neutral and cut his price target for the shares to $90 from $106. The stock closed yesterday up 51c to $99.36. Hershey's portfolio is over-exposed to slowing category consumption, intensifying competition, and rising cocoa prices, Strycula tells investors in a research note. The analyst notes that his firm's research indicates reduced purchase frequency for everyday chocolate as preferences shift consumption to healthier snack alternatives and online purchases. These "longer-tailed trends" carry negative margin mix and potential distribution losses for Hershey, he writes. Further, Strycula sees risk of Hershey losing U.S. share as Mars ramps production capacity, Ferrero revitalizes Nestle's legacy U.S. portfolio and Mondelez (MDLZ) accelerates its entry into U.S. chocolate.
04/10/18
UBSW
04/10/18
DOWNGRADE
UBSW
Sell
Hershey downgraded to Sell from Neutral at UBS
04/12/18
PIPR
04/12/18
INITIATION
Target $99
PIPR
Neutral
Hershey initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery started Hershey with a Neutral rating and $99 price target. The analyst sees higher cocoa costs weighing on the company's margin outlook in the second half of 2018 and 2019. He also believes Hershey's Tyrrells business could still be losing money.
ALV Autoliv
$149.69

0.14 (0.09%)

02/12/18
BMOC
02/12/18
NO CHANGE
Target $175
BMOC
Outperform
Autoliv price target raised to $175 from $152 at BMO Capital
BMO Capital analyst Richard Carlson raised his price target on Autoliv to $175 and kept his Outperform rating after meeting with the company's management last week. Carlson notes that the focus of the discussion was around the pending separation of Autoliv's two business segments, and his sum-of-the-parts analysis suggests that there is some upside remaining. The analyst sees the current market volatility as an appropriate juncture to establish or increase positions in the combined company.
02/28/18
SOCG
02/28/18
DOWNGRADE
Target $140
SOCG
Sell
Autoliv downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Erwann Dagorne downgraded Autoliv to Sell with a $140 price target citing "rich" valuation.
03/05/18
SBSH
03/05/18
NO CHANGE
Target $154
SBSH
Neutral
Autoliv price target raised to $154 from $129 at Citi
Citi analyst Itay Michaeli raised his price target for Autoliv to $154 following management meetings and the company's Q4 results. The meetings yielded greater confidence that Autoliv's two future standalone businesses can achieve prior 2020 objectives, Michaeli tells investors in a research note. The analyst, however, views the stock's current valuation as "reasonable if not somewhat full."
04/11/18
CRSS
04/11/18
INITIATION
CRSS
Hold
Autoliv initiated with a Hold at Cross Research
LPTX Leap Therapeutics
$9.71

0.16 (1.68%)

04/12/18
HCWC
04/12/18
INITIATION
Target $12.5
HCWC
Buy
Leap Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Leap Therapeutics with a Buy rating and $12.50 price target. The company has two novel products targeting the tumor microenvironment, Ramakanth tells investors in a research note. He believes Leap's products could significantly improve the typical 15%-20% response rates seen with current immunotherapies when used in combination.
MPWR Monolithic Power
$116.98

1.14 (0.98%)

07/27/17
NEED
07/27/17
NO CHANGE
Target $140
NEED
Buy
Monolithic Power price target raised to $140 from $100 at Needham
Needham analyst N. Quinn Bolton raised his price target for Monolithic Power to $140 from $100 after the company once again delivered beat and raise results driven by strength across its multiple end markets. The analyst reiterates a Buy rating on the shares.
10/10/17
RHCO
10/10/17
INITIATION
Target $132
RHCO
Buy
Monolithic Power initiated with a Buy at SunTrust
SunTrust analyst William Stein initiated Monolithic Power with a Buy rating and a price target of $132, saying the company is in the early stages of multi-year structural growth and margin expansion. Stein says new products and operating leverage will produce higher sales and EPS growth in the high 20 percentile, adding the company only penetrates about 1% of a $45B semiconductor market expected to benefit from innovations in automotive and motion control technologies.
10/27/17
OPCO
10/27/17
NO CHANGE
Target $130
OPCO
Outperform
Monolithic Power price target raised to $130 from $120 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Monolithic Power to $130 saying he remains a long-term buyer of the shares following yesterday's better than expected results. He notes the company's Q4 outlook points to its 18th consecutive quarter of organic double-digit year-over-year revenue growth. The analyst keeps an Outperform rating on Monolithic.
04/12/18
RAJA
04/12/18
INITIATION
Target $140
RAJA
Strong Buy
Monolithic Power initiated with a Strong Buy at Raymond James
Raymond James analyst Chris Caso initiated Monolithic Power with a Strong Buy rating and a price target of $140. Caso cites the company's strong free cash flows and high-teen revenue growth positioning Monolithic Power into an industry niche. He also notes the company's small size as it helps remove the growth constraints weighing on its larger peers. Over the near term, the analyst sees "strong industry conditions" creating good revenue visibility for Monolithic Power.

TODAY'S FREE FLY STORIES

KMG

KMG Chemicals

$75.99

(0.00%)

15:57
11/15/18
11/15
15:57
11/15/18
15:57
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$107.30

2.3 (2.19%)

, FB

Facebook

$143.53

-0.72 (-0.50%)

15:55
11/15/18
11/15
15:55
11/15/18
15:55
Periodicals
Microsoft joins forces with Facebook on AI software, CNBC says »

Microsoft (MSFT) has…

MSFT

Microsoft

$107.30

2.3 (2.19%)

FB

Facebook

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 28

    Nov

  • 03

    Mar

CVNA

Carvana

$47.87

2.5 (5.51%)

15:55
11/15/18
11/15
15:55
11/15/18
15:55
Options
Carvana put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

B

Barnes Group

$59.18

1.17 (2.02%)

15:55
11/15/18
11/15
15:55
11/15/18
15:55
Conference/Events
Barnes Group to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TOL

Toll Brothers

$29.87

-1.96 (-6.16%)

15:45
11/15/18
11/15
15:45
11/15/18
15:45
Options
Toll Brothers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AAPL

Apple

$190.76

3.95 (2.11%)

15:44
11/15/18
11/15
15:44
11/15/18
15:44
Periodicals
Apple partners with A24 to make feature-length movies, Variety says »

Apple is enlisting indie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$191.08

4.27 (2.29%)

15:42
11/15/18
11/15
15:42
11/15/18
15:42
Periodicals
Breaking Periodicals news story on Apple »

Apple and movie studio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$34.97

-1.54 (-4.22%)

15:41
11/15/18
11/15
15:41
11/15/18
15:41
Hot Stocks
British American says menthol cigarettes should not be treated 'differently' »

In a statement regarding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:38
11/15/18
11/15
15:38
11/15/18
15:38
Hot Stocks
Breaking Hot Stocks news story  »

Greenpro Capital…

WTW

Weight Watchers

$49.93

0.91 (1.86%)

15:37
11/15/18
11/15
15:37
11/15/18
15:37
Conference/Events
Weight Watchers management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

WSM

Williams-Sonoma

$60.33

-1.43 (-2.32%)

15:34
11/15/18
11/15
15:34
11/15/18
15:34
Options
Williams Sonoma options imply 10.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

15:33
11/15/18
11/15
15:33
11/15/18
15:33
Hot Stocks
Breaking Hot Stocks news story  »

Greenpro Capital…

QLYS

Qualys

$74.55

2.63 (3.66%)

15:32
11/15/18
11/15
15:32
11/15/18
15:32
Conference/Events
Qualys management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Jan

FAST

Fastenal

$57.06

1.21 (2.17%)

15:30
11/15/18
11/15
15:30
11/15/18
15:30
Options
Timely sweep of Fastenal calls »

Timely sweep of Fastenal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.54

2.35 (0.87%)

15:28
11/15/18
11/15
15:28
11/15/18
15:28
Hot Stocks
Assistant AG Delrahim says DOJ seeks to curtail bid-rigging in gov't purchases »

Assistant Attorney…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.54

2.35 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$129.03

4.03 (3.22%)

15:27
11/15/18
11/15
15:27
11/15/18
15:27
Conference/Events
Stanley Black & Decker management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

DDS

Dillard's

$63.35

-10.28 (-13.96%)

15:27
11/15/18
11/15
15:27
11/15/18
15:27
Downgrade
Dillard's rating change  »

Dillard's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$127.24

-0.05 (-0.04%)

15:20
11/15/18
11/15
15:20
11/15/18
15:20
Options
Notable call spread in Universal Health as shares advance »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$58.79

-2.305 (-3.77%)

15:19
11/15/18
11/15
15:19
11/15/18
15:19
Options
Nordstrom options imply 9.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SPY

SPDR S&P 500 ETF Trust

$271.84

1.65 (0.61%)

, SPX

S&P 500

$0.00

(0.00%)

15:17
11/15/18
11/15
15:17
11/15/18
15:17
General news
U.S. official: China trade offer should be viewed with skepticism, Reuters says »

An unnamed U.S.…

SPY

SPDR S&P 500 ETF Trust

$271.84

1.65 (0.61%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/15/18
11/15
15:17
11/15/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/15/18
11/15
15:16
11/15/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$35.42

1.83 (5.45%)

15:04
11/15/18
11/15
15:04
11/15/18
15:04
Options
Applied Materials options imply 6.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RMNI

Rimini Street

$5.45

0.13 (2.44%)

15:04
11/15/18
11/15
15:04
11/15/18
15:04
Hot Stocks
Rimini Street expands investment and operations in Asia-Pacific »

Rimini Street announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$273.24

3.05 (1.13%)

, SPX

S&P 500

$0.00

(0.00%)

15:03
11/15/18
11/15
15:03
11/15/18
15:03
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Ross says U.S. still…

SPY

SPDR S&P 500 ETF Trust

$273.24

3.05 (1.13%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.